Up a level |
Chai, Chee Shee and Ho, Gwo Fuang and Adlinda, Alip and Mohd Ibrahim, Abd Wahid and Matin Mellor, Abdullah and Foo, Yoke Ching and How, Soon Hin and Adel, Zaatar and Lam, Kai Seng and Leong, Kin-Wah and Low, JohnbSeng Hooi and Mastura, Md Yusof and Lee, Erica Chai Yong and Toh, Yok Yong and Liam, Chong Kin (2019) Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study. BMC Cancer, 19 (896). pp. 1-11. ISSN 1471-2407